Sat, Dec 27, 2014, 12:40 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • mecosmo2 mecosmo2 Jan 13, 2014 10:22 AM Flag


    KemPharm is a development stage biopharmaceutical company focused on the discovery and development of new, safer therapies in the areas of pain, ADHD, and other CNS diseases. The company’s primary efforts include the development of safer, abuse resistant opioid pain relievers. The company’s drug discovery and development platform is based on its proprietary Ligand Activated Therapy (LAT) approach. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.

    Sentiment: Strong Buy

1.03+0.02(+1.98%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Rice Energy Inc.
NYSEFri, Dec 26, 2014 4:02 PM EST
Ocwen Financial Corp.
NYSEFri, Dec 26, 2014 4:03 PM EST